xz fbv cbl oq ozo yn zni ab ac kr xz ensg ensmusg nmnmnm nmnmnmnm npnpnp npnpnpnp zap zetachainassoci protein kinas protein normal express near surfac membran lymphocyt cell natur killer cell subset cell promin know recruit upon antigen bind cell receptor tcr play critic role cell signal zap initi discov tcrstimul jurkat cell immort line human lymphocyt molecular weight kda member proteintyrosin kinas famili close homolog syk syk zap share common evolutionari origin split common ancestor jaw vertebr import zap cell activ determin compar zap express patient scid sever combin immunodefici zap defici individu find function cell peripher blood suggest zap critic compon cell activ develop zap express cell correl develop chronic lymphocyt leukemia cll cell receptor innat enzymat activ due cell receptor reli signal molecul transduc signal cell membran zap critic cytoplasm tyrosin kinas initi signal pathway downstream activ cell receptor lymphocyt activ engag cell receptor process antigen fragment present profession antigen present cell ie macrophag dendrit cell langerhan cell cell via mhc upon activ tcr coreceptor cd express helper cell cd express cytotox cell bind mhc activ coreceptor associ tyrosin kinas lck lck move near cd complex phosphoryl tyrosin immunoreceptor tyrosinebas activ motif itam creat dock site zap import member cd famili cdzeta zap bind henc abbrevi tandem shdomain zap engag doubli phosphoryl itam cdzeta posit zap phosphoryl transmembran protein linker activ cell lat phosphoryl lat turn serv dock site number signal protein bind includ shdomaincontain leukocyt protein kda slp slp also phosphoryl zap requir activ src famili kinas final outcom cell activ transcript sever gene product allow cell differenti prolifer secret number cytokin due role lymphocyt signal zap associ sever diseas affect lymphocyt zap express signific indic surviv lymphocyt notabl associ chronic lymphocyt leukemia cll cll cancer develop overproduct cell bone marrow peopl cll high level zap confer bad prognosi cll patient posit marker zap averag surviv year wherea negat zap averag surviv year mani patient especi old one slowli progress diseas reassur may need treatment lifetim individu cll high level zap associ high number malign cell activ increas express zap cell malign correl increas associ malign cell immun environ suggest complex role zap cell signal system lupus erythematosus zap receptor pathway miss homolog syk take place zap defici result form autosom recess immun defici name combin immunodefici patient afflict combin immunodefici normal lymphocyt count low concentr helper cell cytotox cell patient also find irregular lymphocyt prolifer respons effect suggest defici zap result decreas rate cell activ subsequ signal transduct zap show interact crystal structur apo sh domain zap crystal structur zap kinas domain complex staurosporin oq tandem sh domain zap mer zeta peptid ozo autoinhibit intact human zap